Smallpox vaccine - Therion BiologicsAlternative Names: TBC-MVA
Latest Information Update: 03 Apr 2007
At a glance
- Originator Therion Biologics
- Developer National Institutes of Health (USA); Therion Biologics
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Smallpox
Most Recent Events
- 24 Dec 2002 Phase-I clinical trials in Smallpox in USA (unspecified route)